Díaz Molina Raúl José, Comesaña Castellar Carlos, Crespí Rigo Joan, Radu Tomsa Catalina, Quesada Bauzá Patricia, Porcel Corra Isabel, Sendra Rumbeu Pau, Royo Escosa Vanesa, Herrera González María Dolores, Puchol Segarra Eva, Ginard Vicens Daniel
Gastroenterology Department, Son Espases University Hospital, Carretera Valldemossa, 79, 07010 Palma de Mallorca, Spain.
Gastroenterology Department, Son Espases University Hospital, Carretera Valldemossa, 79, 07010 Palma de Mallorca, Spain.
Gastroenterol Hepatol. 2025 Apr;48(4):502236. doi: 10.1016/j.gastrohep.2024.502236. Epub 2024 Aug 22.
Virtual reality (VR) is a neurosensory experience in which simulated spaces a person has the sensation of being able to function within them. Some patients with inflammatory bowel disease (IBD) receive intravenous biological treatments in an Adult Day Hospital (ADH) regime. VR has been used in some fields of medicine, demonstrating its usefulness in reducing negative symptoms. However, we do not have any literature showing the applicability in real clinical practice of VR in IBD.
Descriptive observational pilot study based on an initial cohort of 87 patients that were obtained from the ADH of the IBD Unit. Satisfaction and acceptance of VR through the use of 3D glasses and the reduction of negative symptoms during intravenous biological treatment in patients with IBD in ADH have been assessed.
43 patients (52.4%) used VR and completed the study. In the comparative analysis of the results of the questionnaires before and after the use of VR, a statistically significant improvement was observed in the patients' view on the ability of VR to achieve a reduction in stress (65% patients improve; p: 0.0021) and pain (VAS, 54% p. improve; p<0.05) during treatment. Likewise, with the applicability of VR in other areas of medicine (53%; p: 0.05) and with the possibility of improving well-being during the stay in the ADH (56%; p: 0.0014). No side effects were reported with the use of the 3D glasses.
VR is a useful complementary tool to improve the stay of patients with IBD on ADH during intravenous treatment.
虚拟现实（VR）是一种神经感觉体验，在模拟空间中，人们能够产生在其中发挥功能的感觉。一些炎症性肠病（IBD）患者在成人日间医院（ADH）接受静脉生物治疗。VR已在医学的某些领域得到应用，显示出其在减轻负面症状方面的作用。然而，尚无文献表明VR在IBD实际临床实践中的适用性。
基于从IBD科室的ADH获取的87名患者的初始队列进行描述性观察性试点研究。评估了IBD患者在ADH接受静脉生物治疗期间通过使用3D眼镜对VR的满意度和接受度以及负面症状的减轻情况。
43名患者（52.4%）使用了VR并完成了研究。在对使用VR前后问卷结果的对比分析中，观察到患者对VR减轻压力能力的看法有统计学意义的改善（65%的患者有所改善；p：0.0021）以及治疗期间疼痛的减轻（视觉模拟评分法，54%的患者有所改善；p<0.05）。同样，VR在医学其他领域的适用性（53%；p：0.05）以及在ADH停留期间改善幸福感的可能性（56%；p：0.0014）也有改善。使用3D眼镜未报告有副作用。
VR是一种有用的辅助工具，可改善IBD患者在ADH接受静脉治疗期间的体验。
